World’s best-selling drug costs five times more in U.S. than Europe

Critics accuse the maker of Humira of exploiting patent laws to keep competitors’ less expensive versions off the market. The company, AbbVie, says it’s balancing the need to keep the drug affordable to patients with the need to fund new drug development

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNews /  🏆 10. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Even the best stock-market investors fail when it’s time to sellEven the best stock-market investors fail when it’s time to sell (via MktwHulbert)
Read more »

As medical costs mount, Japan to weigh cost-effectiveness in setting drug pricesJapanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an ...
Read more »

I drove the world's best-selling electric car for a weekend — and I realized why electric cars need more than 200 miles of rangeI drove the 2018 Nissan Leaf for a weekend in December.
Read more »